Technology

March 11, 2010 – The FDA cleared a new family of introducers which offer features intended to minimize trauma to the artery and set the stage for closure using a closure device. The products also recently gained European CE mark approval.

Home March 11, 2010
Home
Technology

Vascular Solutions offers a variety of hemostasis products used to stop bleeding. D-Stat products rely on biologically active components to induce bleeding cessation.The products use thrombin, a natural component of the clotting cascade. Thrombin cleaves fibrinogen to fibrin, enhancing the body's own ability to produce clot. D-Stat Dry

Home March 11, 2010
Home
Feature

March 12, 2010 – In partnership with the American College of Cardiology (ACC), Philips is spotlighting the growing need for hybrid cath labs with a specialty exhibit during ACC 2010 March 14-16 in Atlanta.

Home March 11, 2010
Home
Technology

Vytorin is a medicine used to lower levels of total cholesterol, LDL (bad) cholesterol, and fatty substances called triglycerides in the blood. The prescription-only medication is intended for patients who cannot control their cholesterol levels by diet and exercise alone.

Home March 10, 2010
Home
Technology

March 10, 2010 - To help clinicians communicate about radiation dose exposure during radiological procedures, a new dose-saving solution for use in interventional radiology procedures is now available.

Home March 10, 2010
Home
Technology

Unlike the most common cholesterol-lowering medicines, statins, that work mainly in the liver, a new drug attempts to fight cholesterol by focusing on the digestive tract.

Home March 10, 2010
Home
Technology

An FDA-approved, cholesterol-lowering medication has been proven to significantly reduce the risk of heart attack, stroke, certain kinds of heart surgeries and chest pain.

Home March 10, 2010
Home
Feature | Dave Fornell

Lowering radiation dose and improving navigation abilities of angiography systems have been among the top priorities of manufactures over the past year. Another big trend is integration of angiography systems in hybrid cath lab/operating rooms (ORs) as collaboration between surgeons and interventionalists improves with increasingly less-invasive procedures.

Home March 10, 2010
Home
Feature | Jerome E. Granato, M.D.

Editor’s note: Jerome Granato, M.D., is the medical director of the coronary care unit at Allegheny General Hospital in Pittsburgh, Pa. His facility started looking at ways to cut its nosocomial infection rates several years ago. This issue has a broader importance today, with CMS now cutting reimbursements for hospital-acquired infections and other “never events.”

Home March 10, 2010
Home
Feature | Dave Fornell

The FDA’s approval of the Melody valve is widely viewed as a positive sign that may help other transcatheter valves to follow.

Home March 10, 2010
Home
Feature | Dave Fornell

The FDA recently gave market clearance for Medtronic’s Melody Transcatheter Pulmonary Valve, the first transcatheter valve approved in the United States. The cardiology community expects this to be the first of many transcatheter valves to come, which are predicted to replace open-heart surgery with much less-invasive cath lab procedures.

Home March 09, 2010
Home
News

March 10, 2010 - The third annual Workstation Face-Off at the 22nd European Congress of Radiology, held in Vienna, Austria, and hosted by radiologists Anno Graser M.D., and Christoph Becker, M.D., of the Ludwig-Maximillians University in Munich, featured two challenging cases involving oncology and perfusion imaging and analysis with CT and PET, for three sequential timepoints.

Home March 09, 2010
Home
Feature | Darhiana Mateo

As cutting-edge technologies collide with innovative surgical and interventional treatments for multiple coronary or vascular issues, a hybrid approach is emerging as the best path of action.

Home March 09, 2010
Home
Feature | Dave Fornell

The general public usually does not take a big interest in cardiology or the interventional devices used to treat cardiac conditions until a family member or someone famous makes headlines due to a cardiac condition. Stents were brought back to mainstream national and international headlines recently after former President Bill Clinton received two stents at New York Presbyterian Hospital.

Home March 09, 2010
Home
Feature | Dave Fornell

March 9, 2010 – The most recent data from 30 late-breaking clinical trials is being highlighted during the American College of Cardiology (ACC) 2010 scientific sessions, March 14-16 in Atlanta.

Home March 09, 2010
Home
Subscribe Now